bpc 157 safety evidence human studies Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review BPC-157: Experimental Peptide Creates Risk

Though in vitro data and in vivo animal data thus far is promising, more information and human trials are needed to evaluate the potential role of methylene blue as a treatment for acute and chronic brain injuries

See our BPC-157 guide and TB-500 guide for complete protocols

Feeling fine after taking something is not the same as it being established as safe particularly for an injectable compound with no approved dose, no long-term human studies, and unresolved questions about immune reactions

Solicited reactogenicity data in 16 and 17 year-old participants are limited

, (MDA)

doi:10.1007/s00394-023-03087-y Clements M, Heffernan M, Ward M, et al